Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: US tech titans, AstraZeneca in focus

Wed, 29th Jul 2020 16:19

(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.




But the US economy won't be far from investors minds either, as the Commerce Department releases second quarter US gross domestic product data that economists at Barclays Research anticipate will show an annualised 35% drop in activity.

Some analysts believe that their updates may well set the tone for over the entire month of August.

In the UK on the other hand, the only noteworthy release will be for motor vehicle production in June.

Across the Channel meanwhile, readings are due out for monthly unemployment in Germany and Italy, alongside second quarter GDP readings in Austria, Belgium and Germany.



The earnings calendar for the UK is full on Thursday

In the case of AstraZeneca, UBS analyst Michael Leuchten sees first half revenues coming in at $6.33bn (consensus: $6.25bn) and core earnings per share at $0.93 (consensus: $0.92).

Focus would be on the drugmaker's work on a Covid-19 vaccine alongside Oxford University, which was currently considered the front-runner in the global race to find a vaccine.

But concerns around cash generation were likely to resurface as well.

"Top-line momentum remains key for investors, in particular Tagrisso (UBSe of $1,013m vs cons. $1,031m), Lynparza (UBSe of $460m vs cons. $412m) and Imfinzi (UBSe $478m vs cons $465m). Calquence uptake will be of interest (UBSe of $102m vs cons. $103m). We will also look for any commentary around COVID-19 potential impact in H2 and the path to recovery."

Thursday 29 July

FINALS

The Panoply Holdings

INTERIMS

SEGRO, Kcell Joint Stock Co GDR (Reg S), BAE Systems, Franchise Brands, Greencoat UK Wind, Hutchison China Meditech Ltd, Inchcape, Robert Walters, Rentokil Initial, Goco Group, Schroders, AstraZeneca

Q2

Schroders, AstraZeneca, Royal Dutch Shell 'A', Royal Dutch Shell 'B'

TRADING ANNOUNCEMENTS

Compass Group, Gem Diamonds Ltd. (DI), Evraz, Volution Group

AGMs

Norcros, Card Factory, OnTheMarket, BMO Global Smaller Companies, Highland Gold Mining Ltd., Volex, London & Associated Properties, TMT Investments, Angling Direct, Gabelli Value Plus Trust, Stobart Group Ltd.

FINAL EX-DIVIDEND DATE

Anexo Group, Ventus 2 VCT 'C' Shares, Monks Inv Trust, Ventus VCT, Ventus 2 VCT D Shs, Keller Group, Ventus 2 VCT, Ventus VCT D Shs

FINAL DIVIDEND PAYMENT DATE

Anglo Asian Mining

INTERIM EX-DIVIDEND DATE

Investment Company, Hansa Investment Company Limited (DI), Aberdeen Asian Income Fund Ltd., BB Healthcare Trust (Red), Hansa Investment Company Limited 'A' Non Vtg (DI), Independent Inv Trust, Secure Income Reit, RELX plc, Nichols, Blackstone/GSO Loan Financing Limited, Blackrock Throgmorton Trust, GCP Infrastructure Investments Ltd, Aew UK Reit, Value and Income Trust, Henderson International Income Trust, Maven Income and Growth VCT 5, Schroder Real Estate Investment Trust Ltd, Starwood European Real Estate Finance Ltd, GCP Asset Backed Income Fund Limited, Henderson Far East Income Ltd., Maven Income & Growth 3 VCT, Foresight Solar Fund Limited, Ecofin Global Utilities and Infrastructure Trust

INTERIM DIVIDEND PAYMENT DATE

Robinson

SPECIAL EX-DIVIDEND DATE

Keller Group

QUARTERLY EX-DIVIDEND DATE

Marble Point Loan Financing Limited NPV, SME Credit Realisation Fund Limited NPV, City of London Inv Trust

QUARTERLY PAYMENT DATE

Real Estate Credit Investments Ltd

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Unemployment Rate (GER) (08:55)

GDP (Preliminary) (GER) (09:00)

Business Climate Indicator (EU) (10:00)

Industrial Confidence (EU) (10:00)

Economic Sentiment Indicator (EU) (10:00)

Unemployment Rate (EU) (10:00)

Services Sentiment (EU) (10:00)

Services Confidence (EU) (10:00)

GDP (Preliminary) (US) (13:30)

Continuing Claims (US) (13:30)

Initial Jobless Claims (US) (13:30)



More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.